logo-loader
viewEmerald Bioscience Inc.

Emerald Bioscience reveals recent milestones with its CBD-based therapeutic

Emerald BioScience (OTCQB:EMBI) CEO Brian Murphy spoke to Proactive at the Biotech Showcase 2020 in San Francisco. The Long Beach, California-based biopharmaceutical company is focused on the discovery, development, and commercialization of bioengineered cannabinoid-based therapeutics.

Quick facts: Emerald Bioscience Inc.

Price: 0.151 USD

OTCQB:EMBI
Market: OTCQB
Market Cap: $27.66 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

KORE Mining is cashed up and ready for exploration on 4 unique projects

KORE Mining (CVE: KORE) CEO Scott Trebilcock joined Steve Darling from Proactive to discuss the company, that is exploring 4 properties including their Imperial project which they just completed a positive PEA. Trebilcock tells Proactive about that gold project and also about their...

1 day, 23 hours ago

2 min read